Article

Old Does Not Necessarily Mean Worse: Standard 6-Week Chemoradiation For Elderly Patients (≥ 70 Years) With Newly Diagnosed Glioblastoma

2021-05-12

Abstract excerpt

<h4>Introduction: </h4> Glioblastoma (GBM) is frequent in elderly patients, but their frailty provokes debate regarding optimal treatment in general, and the standard 6-week chemoradiation in particular, although this is the mainstay for younger patients. <h4>Methods: </h4> All patients with newly diagnosed GBM and age ≥ 70 who were referred to our institution for chemoradiation (RCT) were reviewed from 2004 to 20...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 62bad187-ff57-596b-8263-c31a2dd38ea5
DOI: 10.21203/rs.3.rs-493204/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Old Does Not Necessarily Mean Worse: Standard 6-Week Chemoradiation For Elderly Patients (≥ 70 Years) With Newly Diagnosed GlioblastomaDOI 10.21203/rs.3.rs-493204/v1Read

Old Does Not Necessarily Mean Worse: Standard Stupp Regimen for Elderly Patients (≥ 70 years) with Newly Diagnosed GlioblastomaSemantic proximity Read

Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.Semantic proximity Read

Tailoring Glioblastoma Treatment for Frail Populations: Insights from Genomic and Clinical DataSemantic proximity Read

Timing Matters: Overall Treatment Time, Radiotherapy Interruptions, and Outcomes in glioblastomas – Prognostic Significance in Different Biological Sub- GroupsSemantic proximity Read

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma.Semantic proximity Read

Could upfront temozolomide chemotherapy postpone the intervene of radiotherapy in young patients with high-risk low-grade gliomas?Semantic proximity Read

Practice-Changing Abstracts From the 2016 Society for Neuro-Oncology Annual Scientific Meeting.Semantic proximity Read

No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patientsSemantic proximity Read

Accelerated Hyper-Versus Normofractionated Radiochemotherapy with Temozolomide in Patients with Glioblastoma: A Multicenter Retrospective Analysis.Semantic proximity Read

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).Semantic proximity Read

Experience about Chemoradiation treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Newly Diagnosed Glioblastoma (GBM) Patients in ChinaSemantic proximity Read

Management of Elderly Patients with Glioblastoma.Semantic proximity Read